Ocular Therapeutix, Inc.   Report issue

Founded: Bedford MA United States (2006)
Status: No NME R&D (2006)

Organization Overview

First Clinical Trial
2012
NCT01666210
First Marketed Drug
2018
dexamethasone
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Ocular Therapeutix | OCULAR THERAPEUTIX | Ocular Therapeutix, Inc.